Brain tumour segmentation with incomplete imaging data

Progress in neuro-oncology is increasingly recognized to be obstructed by the marked heterogeneity—genetic, pathological, and clinical—of brain tumours. If the treatment susceptibilities and outcomes of individual patients differ widely, determined by the interactions of many multimodal characterist...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruffle, James K, Mohinta, Samia, Gray, Robert, Hyare, Harpreet, Nachev, Parashkev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144694/
https://www.ncbi.nlm.nih.gov/pubmed/37124946
http://dx.doi.org/10.1093/braincomms/fcad118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144694/
https://www.ncbi.nlm.nih.gov/pubmed/37124946
http://dx.doi.org/10.1093/braincomms/fcad118

Ejemplares similares